Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

67 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Recommendations to overcome barriers to the use of artificial intelligence-driven evidence in health technology assessment.
Zemplényi A, Tachkov K, Balkanyi L, Németh B, Petykó ZI, Petrova G, Czech M, Dawoud D, Goettsch W, Gutierrez Ibarluzea I, Hren R, Knies S, Lorenzovici L, Maravic Z, Piniazhko O, Savova A, Manova M, Tesar T, Zerovnik S, Kaló Z. Zemplényi A, et al. Among authors: tesar t. Front Public Health. 2023 Apr 26;11:1088121. doi: 10.3389/fpubh.2023.1088121. eCollection 2023. Front Public Health. 2023. PMID: 37181704 Free PMC article.
Pricing and Reimbursement of Biosimilars in Central and Eastern European Countries.
Kawalec P, Stawowczyk E, Tesar T, Skoupa J, Turcu-Stiolica A, Dimitrova M, Petrova GI, Rugaja Z, Männik A, Harsanyi A, Draganic P. Kawalec P, et al. Among authors: tesar t. Front Pharmacol. 2017 Jun 8;8:288. doi: 10.3389/fphar.2017.00288. eCollection 2017. Front Pharmacol. 2017. PMID: 28642700 Free PMC article.
Pharmaceutical Regulation in Central and Eastern European Countries: A Current Review.
Kawalec P, Tesar T, Vostalova L, Draganic P, Manova M, Savova A, Petrova G, Rugaja Z, Männik A, Sowada C, Stawowczyk E, Harsanyi A, Inotai A, Turcu-Stiolica A, Gulbinovič J, Pilc A. Kawalec P, et al. Among authors: tesar t. Front Pharmacol. 2017 Dec 18;8:892. doi: 10.3389/fphar.2017.00892. eCollection 2017. Front Pharmacol. 2017. PMID: 29326583 Free PMC article.
Patient Access, Unmet Medical Need, Expected Benefits, and Concerns Related to the Utilisation of Biosimilars in Eastern European Countries: A Survey of Experts.
Inotai A, Csanadi M, Petrova G, Dimitrova M, Bochenek T, Tesar T, York K, Fuksa L, Kostyuk A, Lorenzovici L, Omelyanovskiy V, Egyed K, Kalo Z. Inotai A, et al. Among authors: tesar t. Biomed Res Int. 2018 Jan 10;2018:9597362. doi: 10.1155/2018/9597362. eCollection 2018. Biomed Res Int. 2018. PMID: 29546072 Free PMC article.
Comparative Analysis of Legislative Requirements About Patients' Access to Biotechnological Drugs for Rare Diseases in Central and Eastern European Countries.
Kamusheva M, Manova M, Savova AT, Petrova GI, Mitov K, Harsányi A, Kaló Z, Márky K, Kawalec P, Angelovska B, Lakić D, Tesar T, Draganic P, Geitona M, Hatzikou M, Paveliu MS, Männik A. Kamusheva M, et al. Among authors: tesar t. Front Pharmacol. 2018 Jul 20;9:795. doi: 10.3389/fphar.2018.00795. eCollection 2018. Front Pharmacol. 2018. PMID: 30079023 Free PMC article.
Reimbursement Legislations and Decision Making for Orphan Drugs in Central and Eastern European Countries.
Malinowski KP, Kawalec P, Trąbka W, Czech M, Petrova G, Manova M, Savova A, Draganić P, Vostalová L, Slabý J, Männik A, Márky K, Rugaja Z, Gulbinovic J, Tesar T, Paveliu MS. Malinowski KP, et al. Among authors: tesar t. Front Pharmacol. 2019 May 8;10:487. doi: 10.3389/fphar.2019.00487. eCollection 2019. Front Pharmacol. 2019. PMID: 31139080 Free PMC article.
67 results